Cover Image

Caspase-3 can not be Used to Predict the Response to Neoadjuvant Chemotherapy Regiment PVB in Cervical Cancer Stage IB-IIA

Objectives: To determine the factors that may be used as the prognostic parameter for the therapeutic efficacy of neoadjuvant chemotherapy, which can be used to revising the management of early stage cervical cancer patients with large lesions. Methods: This was a retrospective cohort study. The stu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ediwibowo Ambari (Author), Hariyono Winarto (Author), Bambang Sutrisna (Author), Budiningsih Siregar (Author)
Format:	Book
Published:	Indonesian Society of Obstetrics and Gynecology, 2013-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recurrence-Free Survival Stage IB1-IIA2 Intermediate Risk Group (Based on Kartu Delgado) Cervical Carcinoma after Radical Surgery and Adjuvant Radiotherapy
by: Andi Friadi, et al.
Published: (2014)

The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers
by: Aysun ALCI, et al.
Published: (2024)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
by: Pingping Liu, et al.
Published: (2022)

Survival and Side Effects of Cisplatin/Cyclophosphamide and Carboplatin/Paclitaxel Adjuvant Chemotherapy in Stage IC-IV Ovarian Cancer
by: Unedo H Markus, et al.
Published: (2015)

Results of dose-dense neoadjuvant chemotherapy in the treatment of stages IB2-IIB cervical cancer
by: A. S. Mamontova, et al.
Published: (2023)

The Outcomes of Primary Debulking Surgery and Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
by: Dino Rinaldy, et al.
Published: (2016)

Tailoring neoadjuvant chemotherapy for a pregnant patient diagnosed with IB2 squamous cervical carcinoma
by: Anna Babkova, et al.
Published: (2024)

MANEJO DEL CÁNCER CERVICOUTERINO IB2-IIA
by: José A Solis C
Published: (2004)

Lower extremity thrombosis and myocarditis due to Human PVB19 infection
by: Ruba Zuhri Yafi, et al.
Published: (2018)

Theurapeutic Response of Neoadjuvant Chemotherapy between Platinum and Ifosfamide Combination and Platinum, Vincristine and Bleomycin Combination in Cervical Carcinoma Stage IB2
by: Kartiwa H Nuryanto, et al.
Published: (2016)

Current management of stage IB2 and bulky IIA, locally advanced, and recurrent cervical carcinoma
by: Karen K. Lo, et al.
Published: (2011)

Is the Initial Treatment in Stage IB2 Cervical Carcinoma Neoadjuvant Chemothreapy or Primary Surgery?
by: Taner Turan, et al.
Published: (2009)

Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy
by: Peng-Hui Wang, et al.
Published: (2014)

Outcomes of Treatment for Cervical Cancer Stage IB2 and IIA2; Radical Hysterectomy and Definitive Radiotherapy
by: Teeraphong Narukon, et al.
Published: (2010)

A case of successful maintained pregnancy after neoadjuvant chemotherapy plus radical surgery for stage IB3 cervical cancer diagnosed at 13 weeks
by: Ying Guo, et al.
Published: (2020)

HE4 has a High Diagnostic Value to Detect Epithelial Ovarian Cancer
by: Bismarck J. Laihad, et al.
Published: (2013)

Correlation Between the Number of Removed Lymph Nodes and Ratio of Lymph Node Metastasis in Stage IB-IIA Cervical Cancer
by: Taner Turan, et al.
Published: (2010)

Quality of Life Assessment in Patient who Underwent Chemotherapy in Gynaecologic Oncology Division
by: Hariyono Winarto, et al.
Published: (2020)

Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis
by: Bei Dong, et al.
Published: (2024)

Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012)

Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
by: Yae Ji Choi, et al.
Published: (2021)

Fascin Expression as Prognostic Factor for Survival in Advanced Epithelial Ovarian Carcinoma
by: Fara Vitantri, et al.
Published: (2015)

Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report
by: Aleksandra Obuchowska, et al.
Published: (2020)

Estudio aleatorio de cirugía radical versus radio-terapia para cáncer cervical estado Ib-IIa
by: Fabio Landoni, et al.
Published: (1997)

Clinical analysis of 312 patients with stage IB1-IIA2 cervical squamous cell carcinoma and research on the influencing factors of postoperative recurrence
by: Jia Zeng, et al.
Published: (2023)

Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
by: Allan B. Huang, et al.
Published: (2021)

The use of neoadjuvant chemotherapy in advanced endometrial cancer
by: L. Philp, et al.
Published: (2021)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020)

Tanshinone IIA inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway
by: Hu Li, et al.
Published: (2015)

Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced-stage peritoneal/ovarian cancer patients
by: Soshi Kusunoki, et al.
Published: (2018)

Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
by: Jiaxi Li, et al.
Published: (2023)

Survival analysis of Stage IIA1 and IIA2 cervical cancer patients
by: Jerry Cheng-Yen Lai, et al.
Published: (2013)

Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study
by: Mehmet Unsal, et al.
Published: (2023)

Neoadjuvant chemotherapy is associated with worse prognosis in patients with advanced-stage epithelial ovarian cancer: Is it real?
by: Yiu-Tai Li, et al.
Published: (2024)

Clinical Evaluation of Neoadjuvant Chemotherapy Followed by Radical Hysterectomy in the Management of Cervical Cancer Stage IIB
by: Rizal Sanif
Published: (2015)

Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?
by: Okan Aytekin, et al.
Published: (2024)

Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
by: Quan Liang, et al.
Published: (2016)

NMMHC IIA Inhibition Ameliorates Cerebral Ischemic/Reperfusion-Induced Neuronal Apoptosis Through Caspase-3/ROCK1/MLC Pathway
by: Wang GY, et al.
Published: (2020)

Role of Neoadjuvant Chemotherapy in High-Grade Neuroendocrine Carcinoma of the Uterine Cervix
by: Hyerim Eum, et al.
Published: (2024)